Details of the Drug Combination

General Information of Drug Combination (ID: DCY5HH8)

Drug Combination Name
MK-4815 JTC-801
Indication
Disease Entry Status REF
DD2 Investigative [1]
Component Drugs MK-4815   DMT9K74 JTC-801   DMV3UN4
N.A. Small molecular drug
2D MOL 2D MOL
3D MOL 3D MOL is unavailable
High-throughput Screening Result Testing Cell Line: DD2
Zero Interaction Potency (ZIP) Score: 13.91
Bliss Independence Score: 14.467
Loewe Additivity Score: 6.674
LHighest Single Agent (HSA) Score: 10.771

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
Indication(s) of MK-4815
Disease Entry ICD 11 Status REF
Malaria 1F40-1F45 Investigative [2]
Indication(s) of JTC-801
Disease Entry ICD 11 Status REF
Pain MG30-MG3Z Discontinued in Phase 2 [3]
JTC-801 Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Nociceptin receptor (OPRL1) TTNT7K8 OPRX_HUMAN Antagonist [4]
------------------------------------------------------------------------------------

Test Results of This Drug Combination in Other Disease Systems

Indication DrugCom ID Cell Line Status REF
Hepatoblastoma DCHXCZK HB3 Investigative [5]
------------------------------------------------------------------------------------

References

1 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125966
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1692).
4 Nociceptin receptor antagonist JTC-801 inhibits nitrous oxide-induced analgesia in mice. J Anesth. 2009;23(2):301-3.
5 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125976